Background: In chronic hypersensitivity pneumonitis (chronic HP), antigen avoidance is critical for disease management; however, complete avoidance is difficult because of unrecognized exposure to antigens. Recently, we revealed that the amount of avian antigen (AAA) in household dust at the time of diagnosis predicted the progression of chronic bird-related HP. The purpose of this study is to evaluate the relationship between the prognosis of chronic bird-related HP and the AAA that remained in the environment during antigen avoidance.
Methods: First, we measured the AAA in household dust of 28 consecutive patients (22 with chronic bird-related HP and 6 with acute bird-related HP) and 12 healthy volunteers. Second, we measured the AAA and collected questionnaires on the environmental conditions of the homes of 53 patients with various lung diseases, including bird-related HP, to investigate the environmental parameters related to a higher AAA. Finally, we prospectively recruited 14 consecutive patients with chronic bird-related HP, measured the AAA periodically, and collected clinical data.
Results: The AAA was higher in patients with chronic bird-related HP at the time of diagnosis compared to healthy volunteers and was highest in patients with acute bird-related HP. Logistic regression analysis showed that birds frequenting a residence was the only significant factor for a higher AAA (odds ratio, 5.686; 95%CI, 1.263-25.59; P = 0.024). There was a correlation between the mean AAA and decline of vital capacity for 1 year (r = -0.55; 95%CI -0.84 to -0.01; P = 0.043).
Conclusion: Measurements of the AAA after diagnosis predict the progression of chronic bird-related HP. Avian antigen can exist in the indoor environment regardless of antigen avoidance. The presence of avian antigen in the indoor environment can be attributed to wild birds found outdoors.
Keywords: Antigen avoidance; avian antigen; chronic hypersensitivity pneumonitis.
© 2017 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd.